296 related articles for article (PubMed ID: 22888353)
1. TCA Cycle Defects and Cancer: When Metabolism Tunes Redox State.
Cardaci S; Ciriolo MR
Int J Cell Biol; 2012; 2012():161837. PubMed ID: 22888353
[TBL] [Abstract][Full Text] [Related]
2. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
Laurenti G; Tennant DA
Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
[TBL] [Abstract][Full Text] [Related]
3. The functional roles of TCA cycle metabolites in cancer.
Eniafe J; Jiang S
Oncogene; 2021 May; 40(19):3351-3363. PubMed ID: 33864000
[TBL] [Abstract][Full Text] [Related]
4. Revisiting the TCA cycle: signaling to tumor formation.
Raimundo N; Baysal BE; Shadel GS
Trends Mol Med; 2011 Nov; 17(11):641-9. PubMed ID: 21764377
[TBL] [Abstract][Full Text] [Related]
5. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase.
Pollard PJ; Wortham NC; Tomlinson IP
Ann Med; 2003; 35(8):632-9. PubMed ID: 14708972
[TBL] [Abstract][Full Text] [Related]
6. The impact of RNA binding proteins and the associated long non-coding RNAs in the TCA cycle on cancer pathogenesis.
Shen T; Wang H; Tang B; Zhu G; Wang X
RNA Biol; 2023 Jan; 20(1):223-234. PubMed ID: 37221841
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the TCA cycle reveals an ATF4-dependent integration of redox and amino acid metabolism.
Ryan DG; Yang M; Prag HA; Blanco GR; Nikitopoulou E; Segarra-Mondejar M; Powell CA; Young T; Burger N; Miljkovic JL; Minczuk M; Murphy MP; von Kriegsheim A; Frezza C
Elife; 2021 Dec; 10():. PubMed ID: 34939929
[TBL] [Abstract][Full Text] [Related]
8. Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria.
Wongkittichote P; Cunningham G; Summar ML; Pumbo E; Forny P; Baumgartner MR; Chapman KA
Mol Genet Metab; 2019 Dec; 128(4):444-451. PubMed ID: 31648943
[TBL] [Abstract][Full Text] [Related]
9. Inborn and acquired metabolic defects in cancer.
Frezza C; Pollard PJ; Gottlieb E
J Mol Med (Berl); 2011 Mar; 89(3):213-20. PubMed ID: 21301796
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
Desideri E; Vegliante R; Ciriolo MR
Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
[TBL] [Abstract][Full Text] [Related]
11. Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer.
Godel M; Ortone G; Anobile DP; Pasino M; Randazzo G; Riganti C; Kopecka J
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065551
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
14. Fumarate hydratase in cancer: A multifaceted tumour suppressor.
Schmidt C; Sciacovelli M; Frezza C
Semin Cell Dev Biol; 2020 Feb; 98():15-25. PubMed ID: 31085323
[TBL] [Abstract][Full Text] [Related]
15. The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency.
Bayley JP; Launonen V; Tomlinson IP
BMC Med Genet; 2008 Mar; 9():20. PubMed ID: 18366737
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients.
Bubber P; Hartounian V; Gibson GE; Blass JP
Eur Neuropsychopharmacol; 2011 Mar; 21(3):254-60. PubMed ID: 21123035
[TBL] [Abstract][Full Text] [Related]
17. No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer.
Huang KT; Dobrovic A; Fox SB
BMC Res Notes; 2009 Sep; 2():194. PubMed ID: 19778456
[TBL] [Abstract][Full Text] [Related]
18. Targeting cancer metabolism.
Teicher BA; Linehan WM; Helman LJ
Clin Cancer Res; 2012 Oct; 18(20):5537-45. PubMed ID: 23071355
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in genes of tricarboxylic acid cycle key enzymes predict postsurgical overall survival of patients with hepatocellular carcinoma.
Du X; Wan S; Chen Y; Qu P; Huang X; Yu X; Yang H; Zhang Y; Xing J
Ann Surg Oncol; 2014 Dec; 21(13):4300-7. PubMed ID: 25081338
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy.
Li L; Eid JE; Paz AC; Trent JC
BioDrugs; 2017 Oct; 31(5):379-392. PubMed ID: 28840584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
